PATENT CLAIM ANALYSIS

Application Number: 15968524
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-08
Patent Classification: ["514", "230500"]

Abstract:
The invention provides compounds and compositions comprising compounds that modulate histone acyl transferase (HAT). The invention further provides methods for treating neurodegenerative disorders, conditions associated with accumulated amyloid-beta peptide deposits, Tau protein levels and/or accumulations of alpha-synuclein as well as cancer by administering a compound hat modulates HAT to a subject.

Claim (Index 12):
The method of  claim 8 , wherein the compound is:

Metadata:
- Claim Count in Document: 49.0
- Percentile: 93.0
- Lexical Diversity: 1.1875
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13996483', '15222734', '15619671', '15331777', '14204076']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7513393829904196
- 35 USC 102 Novelty (BERT): 0.5211982772082346
- Combined Prediction Score: 0.7283252724122011
- Mean Citation Score: 251.510662
- Max Citation Score: 263.77826
- Similarity Product: 144.70517348109362

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test